|
|
|
5,001-10,000 employees
View all
|
|
Biotechnology
|
|
Tokyo, Tokyo
|
|
Daiichi Sankyo Company, Limited engages in the research, development, manufacture, import, sale, and marketing of pharmaceutical products. The company offers prescription drugs, OTC drugs, and quasi-drugs. Its principal products include Olmetec, Rezaltas, Calblock, and Mevalotin for cardiovascular diseases; Cravit for infectious diseases; Loxonin for bone/joint diseases; and Urief for urological diseases. The company also offers vaccines. In addition, the company is developing products for various diseases, which are under various clinical trial stages. Further, it manufactures and sells cosmetics, medical equipment, food, and beverages, as well as veterinary medicines; and manufactures active pharmaceutical ingredients and intermediates. Daiichi Sankyo primarily operates in Japan, North America, Europe, and India. The company is headquartered in Tokyo, Japan.
|
Joe Pieroni is the CEO of Daiichi Sankyo. To contact Joe Pieroni email at [email protected] or [email protected].
The decision makers in Daiichi Sankyo are Bill Mclean, Bruce Dornseif, Eloi Bosio, etc. Click to Find Daiichi Sankyo decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.